|
1
|
Shi TJ, Zhang MD, Zeberg H, Nilsson J,
Grünler J, Liu SX, Xiang Q, Persson J, Fried KJ, Catrina SB, et al:
Coenzyme Q10 prevents peripheral neuropathy and attenuates neuron
loss in the db-/db- mouse, a type 2 diabetes model. Proc Natl Acad
Sci USA. 110:690–695. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Haw JS, Tantry S, Vellanki P and Pasquel
FJ: National strategies to decrease the burden of diabetes and its
complications. Curr Diab Rep. 15:652015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Palmer BF and Clegg DJ: Electrolyte and
acid-base disturbances in patients with diabetes mellitus. N Engl J
Med. 373:548–559. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bouton MC, Boulaftali Y, Richard B, Arocas
V, Michel JB and Jandrot-Perrus M: Emerging role of
serpinE2/protease nexin-1 in hemostasis and vascular biology.
Blood. 119:2452–2457. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Valiente M, Obenauf AC, Jin X, Chen Q,
Zhang XH, Lee DJ, Chaft JE, Kris MG, Huse JT, Brogi E and Massagué
J: Serpins promote cancer cell survival and vascular co-option in
brain metastasis. Cell. 156:1002–1016. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Santoro A, Conde J, Scotece M, Abella V,
Lois A, Lopez V, Pino J, Gomez R, Gomez-Reino JJ and Gualillo O:
SERPINE2 inhibits IL-1α-induced MMP-13 expression in human
chondrocytes: Involvement of ERK/NF-κB/AP-1 pathways. PLoS One.
10:e01359792015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Alsaweed M, Lai CT, Hartmann PE, Geddes DT
and Kakulas F: Human milk miRNAs primarily originate from the
mammary gland resulting in unique miRNA profiles of fractionated
milk. Sci Rep. 6:206802016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yuan Y, Kang R, Yu Y, Liu J, Zhang Y, Shen
C, Wang J, Wu P, Shen C and Wang Z: Crosstalk between miRNAs and
their regulated genes network in stroke. Sci Rep. 6:204292016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Inui M, Martello G and Piccolo S: MicroRNA
control of signal transduction. Nat Rev Mol Cell Biol. 11:252–263.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hur K, Toiyama Y, Okugawa Y, Ide S, Imaoka
H, Boland CR and Goel A: Circulating microRNA-203 predicts
prognosis and metastasis in human colorectal cancer. Gut.
66:654–665. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu FY, Zhou SJ, Deng YL, Zhang ZY, Zhang
EL, Wu ZB, Huang ZY and Chen XP: MiR-216b is involved in
pathogenesis and progression of hepatocellular carcinoma through
HBx-miR-216b-IGF2BP2 signaling pathway. Cell Death Dis.
6:e16702015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu FY, Deng YL, Li Y, Zeng D, Zhou ZZ,
Tian DA and Liu M: Down-regulated KLF17 expression is associated
with tumor invasion and poor prognosis in hepatocellular carcinoma.
Med Oncol. 30:4252013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang X, Li W, Ma L, Gao J, Liu J, Ping F
and Nie M: Association study of the miRNA-binding site
polymorphisms of CDKN2A/B genes with gestational diabetes mellitus
susceptibility. Acta Diabetol. 52:951–958. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen Y, Wang X and Shao X: A combination
of human embryonic stem cell-derived pancreatic endoderm transplant
with LDHA-repressing miRNA can attenuate high-fat diet induced type
II diabetes in mice. J Diabetes Res. 2015:7969122015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Song C, Ji Y, Zou G and Wan C: Tetrandrine
down-regulates expression of miRNA-155 to inhibit signal-induced
NF-κB activation in a rat model of diabetes mellitus. Int J Clin
Exp Med. 8:4024–4030. 2015.PubMed/NCBI
|
|
16
|
Chattopadhyay M, Zhou Z, Hao S, Mata M and
Fink DJ: Reduction of voltage gated sodium channel protein in DRG
by vector mediated miRNA reduces pain in rats with painful diabetic
neuropathy. Mol Pain. 8:172012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-(Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nam JW, Rissland OS, Koppstein D,
Abreu-Goodger C, Jan CH, Agarwal V, Yildirim MA, Rodriguez A and
Bartel DP: Global analyses of the effect of different cellular
contexts on microRNA targeting. Mol Cell. 53:1031–1043. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kozomara A and Griffiths-Jones S: miRBase:
Annotating high confidence microRNAs using deep sequencing data.
Nucleic Acids Res. 42:(Database Issue). D68–D73. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kozomara A and Griffiths-Jones S: miRBase:
Integrating microRNA annotation and deep-sequencing data. Nucleic
Acids Res. 39:(Database Issue). D152–D157. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Griffiths-Jones S, Saini HK, van Dongen S
and Enright AJ: miRBase: Tools for microRNA genomics. Nucleic Acids
Res. 36:(Database Issue). D154–D158. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Griffiths-Jones S, Grocock RJ, van Dongen
S, Bateman A and Enright AJ: miRBase: microRNA sequences, targets
and gene nomenclature. Nucleic Acids Res. 34:(Database issue).
D140–D144. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Griffiths-Jones S: The microRNA registry:
Nucleic Acids Res. 32:(Database issue). D109–D111. 2004.
|
|
24
|
Tornovsky-Babeay S, Dadon D, Ziv O,
Tzipilevich E, Kadosh T, Haroush R Schyr-Ben, Hija A,
Stolovich-Rain M, Furth-Lavi J, Granot Z, et al: Type 2 diabetes
and congenital hyperinsulinism cause DNA double-strand breaks and
p53 activity in beta cells. Cell Metab. 19:109–121. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen BF, Suen YK, Gu S, Li L and Chan WY:
A miR-199a/miR-214 self-regulatory network via PSMD10, TP53 and
DNMT1 in testicular germ cell tumor. Sci Rep. 4:64132014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Seviour EG, Sehgal V, Lu Y, Luo Z, Moss T,
Zhang F, Hill SM, Liu W, Maiti SN, Cooper L, et al: Functional
proteomics identifies miRNAs to target a p27/Myc/phospho-Rb
signature in breast and ovarian cancer. Oncogene. 35:8012016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Thomas H: Diabetes: Enterovirus
dysregulates islet miRNAs. Nat Rev Endocrinol. 12:22016. View Article : Google Scholar
|
|
28
|
Jansen F, Wang H, Przybilla D, Franklin
BS, Dolf A, Pfeifer P, Schmitz T, Flender A, Endl E, Nickenig G and
Werner N: Vascular endothelial microparticles-incorporated
microRNAs are altered in patients with diabetes mellitus.
Cardiovasc Diabetol. 15:492016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kornfeld JW, Baitzel C, Könner AC,
Nicholls HT, Vogt MC, Herrmanns K, Scheja L, Haumaitre C, Wolf AM
and Knippschild U: Obesity-induced overexpression of miR-802
impairs glucose metabolism through silencing of Hnf1b. Nature.
494:111–115. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yousefzadeh N, Alipour MR and Soufi FG:
Deregulation of NF-кB-miR-146a negative feedback loop may be
involved in the pathogenesis of diabetic neuropathy. J Physiol
Biochem. 71:51–58. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pencheva N, Tran H, Buss C, Huh D,
Drobnjak M, Busam K and Tavazoie SF: Convergent multi-miRNA
targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis
and angiogenesis. Cell. 151:1068–1082. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lee CG, Kim YW, Kim EH, Meng Z, Huang W,
Hwang SJ and Kim SG: Farnesoid X receptor protects hepatocytes from
injury by repressing miR-199a-3p, which increases levels of LKB1.
Gastroenterology. 142:1206–17.e7. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Alemdehy MF, Haanstra JR, de Looper HW,
van Strien PM, Verhagen-Oldenampsen J, Caljouw Y, Sanders MA,
Hoogenboezem R, de Ru AH, Janssen GM, et al: ICL-induced miR139-3p
and miR199a-3p have opposite roles in hematopoietic cell expansion
and leukemic transformation. Blood. 125:3937–3948. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Omouendze PL, Henry VJ, Porte B, Dupré N,
Carmeliet P, Gonzalez BJ, Marret S and Leroux P: Hypoxia-ischemia
or excitotoxin-induced tissue plasminogen activator- dependent
gelatinase activation in mice neonate brain microvessels. PLoS One.
8:e712632013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Garibaldi F, Falcone E, Trisciuoglio D,
Colombo T, Lisek K, Walerych D, Del Sal G, Paci P, Bossi G, Piaggio
G and Gurtner A: Mutant p53 inhibits miRNA biogenesis by
interfering with the microprocessor complex. Oncogene.
35:3760–3770. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Morimoto Y, Bando YK, Shigeta T, Monji A
and Murohara T: Atorvastatin prevents ischemic limb loss in type 2
diabetes: Role of p53. J Atheroscler Thromb. 18:200–208. 2011.
View Article : Google Scholar : PubMed/NCBI
|
